Filing Flows › Haemonetics (HAE) › Net income
Haemonetics (HAE) net income by quarter
Haemonetics' net income was $46.3M in Q2 FY27 (second quarter fiscal 2027), +40% from Q1 FY27. Over the last 6 quarters it ranged from $33.0M (Q1 FY27) to $58.0M (Q4 FY25).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | $46.3M | +40% | +20% |
| Q1 FY27 | $33.0M | -26% | -3% |
| Q3 FY26 | $44.7M | +16% | — |
| Q2 FY26 | $38.7M | +14% | — |
| Q1 FY26 | $34.0M | -41% | — |
| Q4 FY25 | $58.0M | — | — |
Q2 FY27 at a glance
Haemonetics, Q2 FY27: revenue $358M (+9% year over year), operating margin 21.0%, net earnings $46.3M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.
Questions
What is Haemonetics' net income?
Haemonetics' net income was $46.3M in Q2 FY27 (second quarter fiscal 2027), +40% from Q1 FY27.
How has Haemonetics' net income changed?
Over the last 6 quarters it ranged from $33.0M (Q1 FY27) to $58.0M (Q4 FY25).